Global Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Regional Outlook and Forecast, 2022 - 2028

The Global Gastrointestinal Therapeutics Market size is expected to reach $45.9 billion by 2028, rising at a market growth of 3.8% CAGR during the forecast period.

Gastrointestinal disorders are associated with the digestive system and usually affect the colon, small & rectum, and large intestine. The conditions include constipation, irritable bowel syndrome, and peptic ulcer disease. The primary causes of GI disorders are stress, intake of medicines like iron pills and anti-depressants, or unhealthy eating habits.

Symptoms of gastrointestinal infections include pain, vomiting, bloating, nausea and vomiting. Various key areas in gastroenterology pharmacotherapy are rapidly evolving, including treating hepatitis C virus (HCV), gastroesophageal reflux disease (GERD), irritable bowel syndrome, and peptic ulcer disease.

HCV treatment has radically changed in the past few years, and now most patients are treatment candidates and have a higher likelihood of a permanent cure. Pharmacotherapy is now the first-line treatment for patients with moderate to severe symptoms of irritable bowel syndrome. Proton pump inhibitors (PPIs) are the pillar of the therapy in gastric and duodenal ulcers and GERD, although long-term use carries the risk of several side effects which should be kept in mind.

When dealing with new therapies, one should always consider whether they are safe, effective, and appropriate to the current treatments. That’s why a time-to-time review of the recent development in the field is required to provide a glimpse of what may lie ahead.

COVID-19 Impact Analysis

The requirement for gastrointestinal therapeutics drugs is expected to remain constant due to the prevalence of GI symptoms through the diagnosis of COVID-19. This is because many of the patients' experience GI complications owing to this infection. Generally reported symptoms to include loss of appetite, nausea, diarrhea, abdominal pain, and others. Therefore, developing new drugs and products and launches, combined with the association of GI manifestations of SARS-CoV-2 with those exhibiting respiratory symptoms, is expected to surge the demand for gastrointestinal therapeutics procedures.

Market Growth Factors

Rising Expenditure on Healthcare

One of the main factors boosting the market's rise is the increasing size and number of investments made in the healthcare system by the government and private organizations of various nations. More developing countries would have greater access to high-quality healthcare due to the fast economic development and growing healthcare cost. Governments of different nations are working on expanding reimbursement options and improving inhabitants' access to good medical services.

Robust Product Development

The rising incidence of gastrointestinal diseases, which ranges from severe to moderate, like ulcerative colitis, Crohn’s disease, and other gastrointestinal diseases, is surging the requirement for advanced therapeutics. As a result, biotechnology and pharmaceutical companies are concentrating more on R&D to discover and develop new products for treating gastrointestinal diseases, increasing their product pipeline. In addition, the increasing development of drugs for gastrointestinal disorders by vendors globally is expected to add to the growth.

Market Restraining Factor

Gastrointestinal Cases Cannot Be Permanently Cured

Chronic gastritis is a common inflammatory disease. In numerous patients, the inflamed gastric mucosa showcases a gradual tendency to become atrophic (atrophic gastritis). Gastritis is generally lifelong, and spontaneous healing is rare with very few expectations, like patients with autoimmune chronic corpus gastritis. Gastritis is connected with the presence of the bacterium Helicobacter pylori. Inflammation and atrophy of the gastric mucosa result in the impairment of gastric secretory functions, for instance, pepsin, secretion of gastric acid, and gastrin. Thus, the absence of proper and permanent treatment for the gastrointestinal disease is expected to hinder the gastrointestinal therapeutics market growth.

Type Outlook

Based on type, the gastrointestinal therapeutics market is segmented branded and generics. The branded segment garnered the highest revenue share in the gastrointestinal therapeutics market in 2021. This is due to the factors like the strong commercial performance of the branded gastrointestinal therapeutics, promising investigational pipeline candidates joined with the premium prices, and market exclusivity. Also, the rising regulatory approvals of branded drugs are anticipated to grow the segment’s growth in the projected period.

Drug Class Outlook

By drug class, the gastrointestinal therapeutics market is fragmented into aminosalicylates, digestive enzymes, proton pump inhibitors, laxatives, anti-emetics, H2 antagonists, anti-diarrheal, biologics/biosimilar and others. The antidiarrheal segment recorded a significant revenue share in the gastrointestinal therapeutics market in 2021. This is due to their usage in the treatment of chronic and acute diseases. They help to reduce the urgency and frequency of the stools passing while also assisting in easing pain, especially if the patient has cramping pain. Antidiarrheal can also be used without the description of a doctor.

Route Of Administration Outlook

On the basis of route of administration, the gastrointestinal therapeutics market is divided into oral, injectable and others. The injectable segment acquired the highest revenue share in the gastrointestinal therapeutics market in 2021. The higher the adoption rate of the biological drugs, the higher prices, rapid onset of action, higher bioavailability, and less possibility of first-pass metabolism in the case of injectable medications are the factors responsible for market’s expansion.

Application Outlook

By application, the gastrointestinal therapeutics market is classified into crohn’s disease, ulcerative colitis, GERD, IBS and others. The crohn’s disease segment garnered the maximum revenue share in the gastrointestinal therapeutics market in 2021. This is due to the increasing incidences of the Crohn’s diseases (CD) in the last 5 decades, the rising approval of the novel drugs for CD and the numerous diagnostic techniques for the Crohn’s disease like imaging modalities or serological markers which are helping in both monitoring and diagnosis, are expected to increase the market for crohn’s disease in the projected period.

Distribution Channel Outlook

Based on distribution channel, the gastrointestinal therapeutics market is bifurcated into hospital pharmacies, retail pharmacies and online pharmacies. The online pharmacies segment recorded a substantial revenue share in the gastrointestinal therapeutics market in 2021. This is due to the growing internet penetration, rising online pharmacies trends, and numerous discounts offered by online pharma players. Also, the adoption of telemedicine has increased during the pandemic, which is still growing even after COVID-19, is expected to further raise the market segment in the forecasted period.

Gastrointestinal Therapeutics Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 35.5 Billion
Market size forecast in 2028	USD 45.9 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 3.8% from 2022 to 2028
Number of Pages	336
Number of Tables	580
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Type, Distribution Channel, Route of Administration, Application, Drug Class, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising Expenditure on Healthcare Robust Product Development
Restraints	Gastrointestinal Cases Cannot Be Permanently Cured

Regional Outlook

Region wise, the gastrointestinal therapeutics market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region acquired the highest revenue share in the gastrointestinal therapeutics market in 2021. The region’s growth is result of the presence of many market players in the area, joined with the various strategic initiatives they used. Moreover, there is an increase in disease prevalence and numerous government-funded schemes to promote research activities for gastrointestinal therapeutics, which are increasing the market in the region.

Free Valuable Insights: Global Gastrointestinal Therapeutics Market size to reach USD 45.9 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, AbbVie, Inc., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.), Johnson & Johnson (Janssen Global Services, LLC), AstraZeneca PLC, Bayer AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.

Strategies deployed in Gastrointestinal Therapeutics Market

• Nov-2022: AbbVie received the European Commission Approval for SKYRIZI, a prescription medicine used to treat adults with moderate to severe Crohn's disease and plaque psoriasis. The approval in European Union would add a breakthrough in AbbVie pursuit to broaden its inflammatory bowel disease portfolio.
• Oct-2022: Pfizer came into partnership with Erasca, a California-based clinical-stage precision oncology company to perform the trials of Palbociclib, an inhibitor of CDK4/6. This partnership for trial will allow companies to clinically test the drug along with ERAS-007 for the cure of NRAS-mutant colorectal cancer (CRC) and KRAS-mutant pancreatic ductal adenocarcinoma.
• Mar-2022: AbbVie received FDA approval for RINVOQ, a prescription medicine used to treat adults with moderate to severe ulcerative colitis. Through the approval of RINVOQ as a treatment option, AbbVie continues its advanced research which could help and influence the lives of people suffering from ulcerative colitis.
• Apr-2021: Bausch Health released ENVIVE, a Daily Probiotic Supplement. The product is particularly developed and tested clinically to deliver consumers a new multi-strain, preservative-free probiotic created to help alleviate periodic GI symptoms.
• May-2019: Takeda collaborated with Frazier Healthcare Partners, a provider of growth and venture capital to healthcare companies. This collaboration is aimed to advance Novel Therapeutics including Vonoprazan for the Treatment of Acid-Related Disorders in Europe and North America.
• Aug-2018: Takeda acquired TiGenix, a European cell therapy company. This acquisition would allow Takeda to deliver available options for the treatment of patients suffering from gastrointestinal disorders.
• Aug-2018: Takeda came into partnership with Ambys Medicines, a Biotechnology Research company. This partnership would help accelerate the capability of Takeda to provide regenerative medicine for people with liver ailments.
• Feb-2018: Janssen collaborated with Theravance BioPharma, a company involved in the development of respiratory medicines. This collaboration is for an oral, pan-jak inhibitor drug candidate for the cure of inflammatory bowel disease.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Branded
• Generics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Route of Administration

• Injectable
• Oral & Others

By Application

• Crohn's Disease
• Ulcerative Colitis
• GERD
• IBS
• Others

By Drug Class

• Biologics/Biosimilar
• Anti-Diarrheal
• Anti-Emetics
• Digestive Enzymes
• Aminosalicylates
• Proton Pump Inhibitors
• Laxatives & H2 Antagonists
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• AbbVie, Inc.
• Takeda Pharmaceutical Company Limited
• Pfizer, Inc.
• Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
• Johnson & Johnson (Janssen Global Services, LLC)
• AstraZeneca PLC
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gastrointestinal Therapeutics Market, by Type
1.4.2 Global Gastrointestinal Therapeutics Market, by Distribution Channel
1.4.3 Global Gastrointestinal Therapeutics Market, by Route of Administration
1.4.4 Global Gastrointestinal Therapeutics Market, by Application
1.4.5 Global Gastrointestinal Therapeutics Market, by Drug Class
1.4.6 Global Gastrointestinal Therapeutics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Gastrointestinal Therapeutics Market

Chapter 4. Global Gastrointestinal Therapeutics Market by Type
4.1 Global Branded Market by Region
4.2 Global Generics Market by Region

Chapter 5. Global Gastrointestinal Therapeutics Market by Distribution Channel
5.1 Global Retail Pharmacies Market by Region
5.2 Global Hospital Pharmacies Market by Region
5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Gastrointestinal Therapeutics Market by Route of Administration
6.1 Global Injectable Market by Region
6.2 Global Oral & Others Market by Region

Chapter 7. Global Gastrointestinal Therapeutics Market by Application
7.1 Global Crohn's Disease Market by Region
7.2 Global Ulcerative Colitis Market by Region
7.3 Global GERD Market by Region
7.4 Global IBS Market by Region
7.5 Global Others Market by Region

Chapter 8. Global Gastrointestinal Therapeutics Market by Drug Class
8.1 Global Biologics/Biosimilar Market by Region
8.2 Global Anti-Diarrheal Market by Region
8.3 Global Anti-Emetics Market by Region
8.4 Global Digestive Enzymes Market by Region
8.5 Global Aminosalicylates Market by Region
8.6 Global Proton Pump Inhibitors Market by Region
8.7 Global Laxatives & H2 Antagonists Market by Region
8.8 Global Others Market by Region

Chapter 9. Global Gastrointestinal Therapeutics Market by Region
9.1 North America Gastrointestinal Therapeutics Market
9.1.1 North America Gastrointestinal Therapeutics Market by Type
9.1.1.1 North America Branded Market by Country
9.1.1.2 North America Generics Market by Country
9.1.2 North America Gastrointestinal Therapeutics Market by Distribution Channel
9.1.2.1 North America Retail Pharmacies Market by Country
9.1.2.2 North America Hospital Pharmacies Market by Country
9.1.2.3 North America Online Pharmacies Market by Country
9.1.3 North America Gastrointestinal Therapeutics Market by Route of Administration
9.1.3.1 North America Injectable Market by Country
9.1.3.2 North America Oral & Others Market by Country
9.1.4 North America Gastrointestinal Therapeutics Market by Application
9.1.4.1 North America Crohn's Disease Market by Country
9.1.4.2 North America Ulcerative Colitis Market by Country
9.1.4.3 North America GERD Market by Country
9.1.4.4 North America IBS Market by Country
9.1.4.5 North America Others Market by Country
9.1.5 North America Gastrointestinal Therapeutics Market by Drug Class
9.1.5.1 North America Biologics/Biosimilar Market by Country
9.1.5.2 North America Anti-Diarrheal Market by Country
9.1.5.3 North America Anti-Emetics Market by Country
9.1.5.4 North America Digestive Enzymes Market by Country
9.1.5.5 North America Aminosalicylates Market by Country
9.1.5.6 North America Proton Pump Inhibitors Market by Country
9.1.5.7 North America Laxatives & H2 Antagonists Market by Country
9.1.5.8 North America Others Market by Country
9.1.6 North America Gastrointestinal Therapeutics Market by Country
9.1.6.1 US Gastrointestinal Therapeutics Market
9.1.6.1.1 US Gastrointestinal Therapeutics Market by Type
9.1.6.1.2 US Gastrointestinal Therapeutics Market by Distribution Channel
9.1.6.1.3 US Gastrointestinal Therapeutics Market by Route of Administration
9.1.6.1.4 US Gastrointestinal Therapeutics Market by Application
9.1.6.1.5 US Gastrointestinal Therapeutics Market by Drug Class
9.1.6.2 Canada Gastrointestinal Therapeutics Market
9.1.6.2.1 Canada Gastrointestinal Therapeutics Market by Type
9.1.6.2.2 Canada Gastrointestinal Therapeutics Market by Distribution Channel
9.1.6.2.3 Canada Gastrointestinal Therapeutics Market by Route of Administration
9.1.6.2.4 Canada Gastrointestinal Therapeutics Market by Application
9.1.6.2.5 Canada Gastrointestinal Therapeutics Market by Drug Class
9.1.6.3 Mexico Gastrointestinal Therapeutics Market
9.1.6.3.1 Mexico Gastrointestinal Therapeutics Market by Type
9.1.6.3.2 Mexico Gastrointestinal Therapeutics Market by Distribution Channel
9.1.6.3.3 Mexico Gastrointestinal Therapeutics Market by Route of Administration
9.1.6.3.4 Mexico Gastrointestinal Therapeutics Market by Application
9.1.6.3.5 Mexico Gastrointestinal Therapeutics Market by Drug Class
9.1.6.4 Rest of North America Gastrointestinal Therapeutics Market
9.1.6.4.1 Rest of North America Gastrointestinal Therapeutics Market by Type
9.1.6.4.2 Rest of North America Gastrointestinal Therapeutics Market by Distribution Channel
9.1.6.4.3 Rest of North America Gastrointestinal Therapeutics Market by Route of Administration
9.1.6.4.4 Rest of North America Gastrointestinal Therapeutics Market by Application
9.1.6.4.5 Rest of North America Gastrointestinal Therapeutics Market by Drug Class
9.2 Europe Gastrointestinal Therapeutics Market
9.2.1 Europe Gastrointestinal Therapeutics Market by Type
9.2.1.1 Europe Branded Market by Country
9.2.1.2 Europe Generics Market by Country
9.2.2 Europe Gastrointestinal Therapeutics Market by Distribution Channel
9.2.2.1 Europe Retail Pharmacies Market by Country
9.2.2.2 Europe Hospital Pharmacies Market by Country
9.2.2.3 Europe Online Pharmacies Market by Country
9.2.3 Europe Gastrointestinal Therapeutics Market by Route of Administration
9.2.3.1 Europe Injectable Market by Country
9.2.3.2 Europe Oral & Others Market by Country
9.2.4 Europe Gastrointestinal Therapeutics Market by Application
9.2.4.1 Europe Crohn's Disease Market by Country
9.2.4.2 Europe Ulcerative Colitis Market by Country
9.2.4.3 Europe GERD Market by Country
9.2.4.4 Europe IBS Market by Country
9.2.4.5 Europe Others Market by Country
9.2.5 Europe Gastrointestinal Therapeutics Market by Drug Class
9.2.5.1 Europe Biologics/Biosimilar Market by Country
9.2.5.2 Europe Anti-Diarrheal Market by Country
9.2.5.3 Europe Anti-Emetics Market by Country
9.2.5.4 Europe Digestive Enzymes Market by Country
9.2.5.5 Europe Aminosalicylates Market by Country
9.2.5.6 Europe Proton Pump Inhibitors Market by Country
9.2.5.7 Europe Laxatives & H2 Antagonists Market by Country
9.2.5.8 Europe Others Market by Country
9.2.6 Europe Gastrointestinal Therapeutics Market by Country
9.2.6.1 Germany Gastrointestinal Therapeutics Market
9.2.6.1.1 Germany Gastrointestinal Therapeutics Market by Type
9.2.6.1.2 Germany Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.1.3 Germany Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.1.4 Germany Gastrointestinal Therapeutics Market by Application
9.2.6.1.5 Germany Gastrointestinal Therapeutics Market by Drug Class
9.2.6.2 UK Gastrointestinal Therapeutics Market
9.2.6.2.1 UK Gastrointestinal Therapeutics Market by Type
9.2.6.2.2 UK Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.2.3 UK Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.2.4 UK Gastrointestinal Therapeutics Market by Application
9.2.6.2.5 UK Gastrointestinal Therapeutics Market by Drug Class
9.2.6.3 France Gastrointestinal Therapeutics Market
9.2.6.3.1 France Gastrointestinal Therapeutics Market by Type
9.2.6.3.2 France Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.3.3 France Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.3.4 France Gastrointestinal Therapeutics Market by Application
9.2.6.3.5 France Gastrointestinal Therapeutics Market by Drug Class
9.2.6.4 Russia Gastrointestinal Therapeutics Market
9.2.6.4.1 Russia Gastrointestinal Therapeutics Market by Type
9.2.6.4.2 Russia Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.4.3 Russia Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.4.4 Russia Gastrointestinal Therapeutics Market by Application
9.2.6.4.5 Russia Gastrointestinal Therapeutics Market by Drug Class
9.2.6.5 Spain Gastrointestinal Therapeutics Market
9.2.6.5.1 Spain Gastrointestinal Therapeutics Market by Type
9.2.6.5.2 Spain Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.5.3 Spain Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.5.4 Spain Gastrointestinal Therapeutics Market by Application
9.2.6.5.5 Spain Gastrointestinal Therapeutics Market by Drug Class
9.2.6.6 Italy Gastrointestinal Therapeutics Market
9.2.6.6.1 Italy Gastrointestinal Therapeutics Market by Type
9.2.6.6.2 Italy Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.6.3 Italy Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.6.4 Italy Gastrointestinal Therapeutics Market by Application
9.2.6.6.5 Italy Gastrointestinal Therapeutics Market by Drug Class
9.2.6.7 Rest of Europe Gastrointestinal Therapeutics Market
9.2.6.7.1 Rest of Europe Gastrointestinal Therapeutics Market by Type
9.2.6.7.2 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel
9.2.6.7.3 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration
9.2.6.7.4 Rest of Europe Gastrointestinal Therapeutics Market by Application
9.2.6.7.5 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class
9.3 Asia Pacific Gastrointestinal Therapeutics Market
9.3.1 Asia Pacific Gastrointestinal Therapeutics Market by Type
9.3.1.1 Asia Pacific Branded Market by Country
9.3.1.2 Asia Pacific Generics Market by Country
9.3.2 Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel
9.3.2.1 Asia Pacific Retail Pharmacies Market by Country
9.3.2.2 Asia Pacific Hospital Pharmacies Market by Country
9.3.2.3 Asia Pacific Online Pharmacies Market by Country
9.3.3 Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration
9.3.3.1 Asia Pacific Injectable Market by Country
9.3.3.2 Asia Pacific Oral & Others Market by Country
9.3.4 Asia Pacific Gastrointestinal Therapeutics Market by Application
9.3.4.1 Asia Pacific Crohn's Disease Market by Country
9.3.4.2 Asia Pacific Ulcerative Colitis Market by Country
9.3.4.3 Asia Pacific GERD Market by Country
9.3.4.4 Asia Pacific IBS Market by Country
9.3.4.5 Asia Pacific Others Market by Country
9.3.5 Asia Pacific Gastrointestinal Therapeutics Market by Drug Class
9.3.5.1 Asia Pacific Biologics/Biosimilar Market by Country
9.3.5.2 Asia Pacific Anti-Diarrheal Market by Country
9.3.5.3 Asia Pacific Anti-Emetics Market by Country
9.3.5.4 Asia Pacific Digestive Enzymes Market by Country
9.3.5.5 Asia Pacific Aminosalicylates Market by Country
9.3.5.6 Asia Pacific Proton Pump Inhibitors Market by Country
9.3.5.7 Asia Pacific Laxatives & H2 Antagonists Market by Country
9.3.5.8 Asia Pacific Others Market by Country
9.3.6 Asia Pacific Gastrointestinal Therapeutics Market by Country
9.3.6.1 China Gastrointestinal Therapeutics Market
9.3.6.1.1 China Gastrointestinal Therapeutics Market by Type
9.3.6.1.2 China Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.1.3 China Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.1.4 China Gastrointestinal Therapeutics Market by Application
9.3.6.1.5 China Gastrointestinal Therapeutics Market by Drug Class
9.3.6.2 Japan Gastrointestinal Therapeutics Market
9.3.6.2.1 Japan Gastrointestinal Therapeutics Market by Type
9.3.6.2.2 Japan Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.2.3 Japan Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.2.4 Japan Gastrointestinal Therapeutics Market by Application
9.3.6.2.5 Japan Gastrointestinal Therapeutics Market by Drug Class
9.3.6.3 India Gastrointestinal Therapeutics Market
9.3.6.3.1 India Gastrointestinal Therapeutics Market by Type
9.3.6.3.2 India Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.3.3 India Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.3.4 India Gastrointestinal Therapeutics Market by Application
9.3.6.3.5 India Gastrointestinal Therapeutics Market by Drug Class
9.3.6.4 South Korea Gastrointestinal Therapeutics Market
9.3.6.4.1 South Korea Gastrointestinal Therapeutics Market by Type
9.3.6.4.2 South Korea Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.4.3 South Korea Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.4.4 South Korea Gastrointestinal Therapeutics Market by Application
9.3.6.4.5 South Korea Gastrointestinal Therapeutics Market by Drug Class
9.3.6.5 Singapore Gastrointestinal Therapeutics Market
9.3.6.5.1 Singapore Gastrointestinal Therapeutics Market by Type
9.3.6.5.2 Singapore Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.5.3 Singapore Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.5.4 Singapore Gastrointestinal Therapeutics Market by Application
9.3.6.5.5 Singapore Gastrointestinal Therapeutics Market by Drug Class
9.3.6.6 Malaysia Gastrointestinal Therapeutics Market
9.3.6.6.1 Malaysia Gastrointestinal Therapeutics Market by Type
9.3.6.6.2 Malaysia Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.6.3 Malaysia Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.6.4 Malaysia Gastrointestinal Therapeutics Market by Application
9.3.6.6.5 Malaysia Gastrointestinal Therapeutics Market by Drug Class
9.3.6.7 Rest of Asia Pacific Gastrointestinal Therapeutics Market
9.3.6.7.1 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Type
9.3.6.7.2 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel
9.3.6.7.3 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration
9.3.6.7.4 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Application
9.3.6.7.5 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Drug Class
9.4 LAMEA Gastrointestinal Therapeutics Market
9.4.1 LAMEA Gastrointestinal Therapeutics Market by Type
9.4.1.1 LAMEA Branded Market by Country
9.4.1.2 LAMEA Generics Market by Country
9.4.2 LAMEA Gastrointestinal Therapeutics Market by Distribution Channel
9.4.2.1 LAMEA Retail Pharmacies Market by Country
9.4.2.2 LAMEA Hospital Pharmacies Market by Country
9.4.2.3 LAMEA Online Pharmacies Market by Country
9.4.3 LAMEA Gastrointestinal Therapeutics Market by Route of Administration
9.4.3.1 LAMEA Injectable Market by Country
9.4.3.2 LAMEA Oral & Others Market by Country
9.4.4 LAMEA Gastrointestinal Therapeutics Market by Application
9.4.4.1 LAMEA Crohn's Disease Market by Country
9.4.4.2 LAMEA Ulcerative Colitis Market by Country
9.4.4.3 LAMEA GERD Market by Country
9.4.4.4 LAMEA IBS Market by Country
9.4.4.5 LAMEA Others Market by Country
9.4.5 LAMEA Gastrointestinal Therapeutics Market by Drug Class
9.4.5.1 LAMEA Biologics/Biosimilar Market by Country
9.4.5.2 LAMEA Anti-Diarrheal Market by Country
9.4.5.3 LAMEA Anti-Emetics Market by Country
9.4.5.4 LAMEA Digestive Enzymes Market by Country
9.4.5.5 LAMEA Aminosalicylates Market by Country
9.4.5.6 LAMEA Proton Pump Inhibitors Market by Country
9.4.5.7 LAMEA Laxatives & H2 Antagonists Market by Country
9.4.5.8 LAMEA Others Market by Country
9.4.6 LAMEA Gastrointestinal Therapeutics Market by Country
9.4.6.1 Brazil Gastrointestinal Therapeutics Market
9.4.6.1.1 Brazil Gastrointestinal Therapeutics Market by Type
9.4.6.1.2 Brazil Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.1.3 Brazil Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.1.4 Brazil Gastrointestinal Therapeutics Market by Application
9.4.6.1.5 Brazil Gastrointestinal Therapeutics Market by Drug Class
9.4.6.2 Argentina Gastrointestinal Therapeutics Market
9.4.6.2.1 Argentina Gastrointestinal Therapeutics Market by Type
9.4.6.2.2 Argentina Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.2.3 Argentina Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.2.4 Argentina Gastrointestinal Therapeutics Market by Application
9.4.6.2.5 Argentina Gastrointestinal Therapeutics Market by Drug Class
9.4.6.3 UAE Gastrointestinal Therapeutics Market
9.4.6.3.1 UAE Gastrointestinal Therapeutics Market by Type
9.4.6.3.2 UAE Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.3.3 UAE Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.3.4 UAE Gastrointestinal Therapeutics Market by Application
9.4.6.3.5 UAE Gastrointestinal Therapeutics Market by Drug Class
9.4.6.4 Saudi Arabia Gastrointestinal Therapeutics Market
9.4.6.4.1 Saudi Arabia Gastrointestinal Therapeutics Market by Type
9.4.6.4.2 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.4.3 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.4.4 Saudi Arabia Gastrointestinal Therapeutics Market by Application
9.4.6.4.5 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class
9.4.6.5 South Africa Gastrointestinal Therapeutics Market
9.4.6.5.1 South Africa Gastrointestinal Therapeutics Market by Type
9.4.6.5.2 South Africa Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.5.3 South Africa Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.5.4 South Africa Gastrointestinal Therapeutics Market by Application
9.4.6.5.5 South Africa Gastrointestinal Therapeutics Market by Drug Class
9.4.6.6 Nigeria Gastrointestinal Therapeutics Market
9.4.6.6.1 Nigeria Gastrointestinal Therapeutics Market by Type
9.4.6.6.2 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.6.3 Nigeria Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.6.4 Nigeria Gastrointestinal Therapeutics Market by Application
9.4.6.6.5 Nigeria Gastrointestinal Therapeutics Market by Drug Class
9.4.6.7 Rest of LAMEA Gastrointestinal Therapeutics Market
9.4.6.7.1 Rest of LAMEA Gastrointestinal Therapeutics Market by Type
9.4.6.7.2 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel
9.4.6.7.3 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration
9.4.6.7.4 Rest of LAMEA Gastrointestinal Therapeutics Market by Application
9.4.6.7.5 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 AbbVie, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Approvals and Trials:
10.3 Takeda Pharmaceutical Company Limited
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisition and Mergers:
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.5 Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.6 Johnson & Johnson (Janssen Global Services, LLC)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental &Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 AstraZeneca PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.8 Bayer AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Sun Pharmaceutical Industries Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.10. Cipla Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense

TABLE 1 Global Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Global Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Global Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Branded Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Branded Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Generics Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Generics Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 10 Global Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 11 Global Retail Pharmacies Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Retail Pharmacies Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Online Pharmacies Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Online Pharmacies Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 18 Global Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 19 Global Injectable Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Injectable Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Oral & Others Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Oral & Others Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 Global Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 Global Crohn's Disease Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Crohn's Disease Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Ulcerative Colitis Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Ulcerative Colitis Market by Region, 2022 - 2028, USD Million
TABLE 29 Global GERD Market by Region, 2018 - 2021, USD Million
TABLE 30 Global GERD Market by Region, 2022 - 2028, USD Million
TABLE 31 Global IBS Market by Region, 2018 - 2021, USD Million
TABLE 32 Global IBS Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 Global Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 Global Biologics/Biosimilar Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Biologics/Biosimilar Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Anti-Diarrheal Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Anti-Diarrheal Market by Region, 2022 - 2028, USD Million
TABLE 41 Global Anti-Emetics Market by Region, 2018 - 2021, USD Million
TABLE 42 Global Anti-Emetics Market by Region, 2022 - 2028, USD Million
TABLE 43 Global Digestive Enzymes Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Digestive Enzymes Market by Region, 2022 - 2028, USD Million
TABLE 45 Global Aminosalicylates Market by Region, 2018 - 2021, USD Million
TABLE 46 Global Aminosalicylates Market by Region, 2022 - 2028, USD Million
TABLE 47 Global Proton Pump Inhibitors Market by Region, 2018 - 2021, USD Million
TABLE 48 Global Proton Pump Inhibitors Market by Region, 2022 - 2028, USD Million
TABLE 49 Global Laxatives & H2 Antagonists Market by Region, 2018 - 2021, USD Million
TABLE 50 Global Laxatives & H2 Antagonists Market by Region, 2022 - 2028, USD Million
TABLE 51 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 52 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 53 Global Gastrointestinal Therapeutics Market by Region, 2018 - 2021, USD Million
TABLE 54 Global Gastrointestinal Therapeutics Market by Region, 2022 - 2028, USD Million
TABLE 55 North America Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 56 North America Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 57 North America Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 58 North America Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 59 North America Branded Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Branded Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Generics Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Generics Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 64 North America Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 65 North America Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 72 North America Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 73 North America Injectable Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Injectable Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 78 North America Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 79 North America Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 83 North America GERD Market by Country, 2018 - 2021, USD Million
TABLE 84 North America GERD Market by Country, 2022 - 2028, USD Million
TABLE 85 North America IBS Market by Country, 2018 - 2021, USD Million
TABLE 86 North America IBS Market by Country, 2022 - 2028, USD Million
TABLE 87 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 88 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 89 North America Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 90 North America Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 91 North America Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 92 North America Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 93 North America Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 94 North America Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 95 North America Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 96 North America Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 97 North America Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 98 North America Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 99 North America Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 100 North America Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 101 North America Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 102 North America Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 103 North America Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 104 North America Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 105 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 106 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 107 North America Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 108 North America Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 109 US Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 110 US Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 111 US Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 112 US Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 113 US Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 114 US Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 115 US Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 116 US Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 117 US Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 118 US Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 119 US Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 120 US Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 121 Canada Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 122 Canada Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 123 Canada Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 124 Canada Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 125 Canada Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 126 Canada Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 127 Canada Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 128 Canada Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 129 Canada Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 130 Canada Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 131 Canada Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 132 Canada Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 133 Mexico Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 134 Mexico Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 135 Mexico Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 136 Mexico Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 137 Mexico Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 138 Mexico Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 139 Mexico Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 140 Mexico Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 141 Mexico Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 142 Mexico Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 143 Mexico Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 144 Mexico Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 145 Rest of North America Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 146 Rest of North America Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 147 Rest of North America Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 148 Rest of North America Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 149 Rest of North America Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 150 Rest of North America Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 151 Rest of North America Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 152 Rest of North America Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 153 Rest of North America Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 154 Rest of North America Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 155 Rest of North America Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 156 Rest of North America Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 157 Europe Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 158 Europe Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 159 Europe Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 160 Europe Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 161 Europe Branded Market by Country, 2018 - 2021, USD Million
TABLE 162 Europe Branded Market by Country, 2022 - 2028, USD Million
TABLE 163 Europe Generics Market by Country, 2018 - 2021, USD Million
TABLE 164 Europe Generics Market by Country, 2022 - 2028, USD Million
TABLE 165 Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 166 Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 167 Europe Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 168 Europe Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 169 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 171 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 172 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 173 Europe Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 174 Europe Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 175 Europe Injectable Market by Country, 2018 - 2021, USD Million
TABLE 176 Europe Injectable Market by Country, 2022 - 2028, USD Million
TABLE 177 Europe Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 178 Europe Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 179 Europe Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 180 Europe Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 181 Europe Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 182 Europe Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 183 Europe Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 184 Europe Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 185 Europe GERD Market by Country, 2018 - 2021, USD Million
TABLE 186 Europe GERD Market by Country, 2022 - 2028, USD Million
TABLE 187 Europe IBS Market by Country, 2018 - 2021, USD Million
TABLE 188 Europe IBS Market by Country, 2022 - 2028, USD Million
TABLE 189 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 190 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 191 Europe Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 192 Europe Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 193 Europe Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 194 Europe Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 195 Europe Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 196 Europe Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 197 Europe Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 198 Europe Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 199 Europe Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 200 Europe Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 201 Europe Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 202 Europe Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 203 Europe Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 204 Europe Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 205 Europe Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 206 Europe Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 207 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 208 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 209 Europe Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 210 Europe Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 211 Germany Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 212 Germany Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 213 Germany Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 214 Germany Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 215 Germany Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 216 Germany Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 217 Germany Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 218 Germany Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 219 Germany Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 220 Germany Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 221 Germany Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 222 Germany Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 223 UK Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 224 UK Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 225 UK Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 226 UK Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 227 UK Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 228 UK Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 229 UK Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 230 UK Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 231 UK Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 232 UK Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 233 UK Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 234 UK Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 235 France Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 236 France Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 237 France Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 238 France Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 239 France Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 240 France Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 241 France Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 242 France Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 243 France Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 244 France Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 245 France Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 246 France Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 247 Russia Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 248 Russia Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 249 Russia Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 250 Russia Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 251 Russia Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 252 Russia Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 253 Russia Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 254 Russia Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 255 Russia Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 256 Russia Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 257 Russia Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 258 Russia Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 259 Spain Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 260 Spain Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 261 Spain Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 262 Spain Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 263 Spain Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 264 Spain Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 265 Spain Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 266 Spain Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 267 Spain Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 268 Spain Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 269 Spain Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 270 Spain Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 271 Italy Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 272 Italy Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 273 Italy Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 274 Italy Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 275 Italy Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 276 Italy Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 277 Italy Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 278 Italy Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 279 Italy Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 280 Italy Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 281 Italy Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 282 Italy Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 283 Rest of Europe Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 284 Rest of Europe Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 285 Rest of Europe Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 286 Rest of Europe Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 287 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 288 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 289 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 290 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 291 Rest of Europe Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 292 Rest of Europe Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 293 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 294 Rest of Europe Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 295 Asia Pacific Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 296 Asia Pacific Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 297 Asia Pacific Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 298 Asia Pacific Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 299 Asia Pacific Branded Market by Country, 2018 - 2021, USD Million
TABLE 300 Asia Pacific Branded Market by Country, 2022 - 2028, USD Million
TABLE 301 Asia Pacific Generics Market by Country, 2018 - 2021, USD Million
TABLE 302 Asia Pacific Generics Market by Country, 2022 - 2028, USD Million
TABLE 303 Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 304 Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 305 Asia Pacific Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 306 Asia Pacific Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 307 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 308 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 309 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 310 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 311 Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 312 Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 313 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
TABLE 314 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
TABLE 315 Asia Pacific Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 316 Asia Pacific Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 317 Asia Pacific Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 318 Asia Pacific Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 319 Asia Pacific Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 320 Asia Pacific Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 321 Asia Pacific Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 322 Asia Pacific Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 323 Asia Pacific GERD Market by Country, 2018 - 2021, USD Million
TABLE 324 Asia Pacific GERD Market by Country, 2022 - 2028, USD Million
TABLE 325 Asia Pacific IBS Market by Country, 2018 - 2021, USD Million
TABLE 326 Asia Pacific IBS Market by Country, 2022 - 2028, USD Million
TABLE 327 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 328 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 329 Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 330 Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 331 Asia Pacific Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 332 Asia Pacific Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 333 Asia Pacific Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 334 Asia Pacific Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 335 Asia Pacific Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 336 Asia Pacific Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 337 Asia Pacific Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 338 Asia Pacific Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 339 Asia Pacific Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 340 Asia Pacific Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 341 Asia Pacific Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 342 Asia Pacific Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 343 Asia Pacific Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 344 Asia Pacific Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 345 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 346 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 347 Asia Pacific Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 348 Asia Pacific Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 349 China Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 350 China Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 351 China Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 352 China Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 353 China Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 354 China Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 355 China Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 356 China Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 357 China Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 358 China Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 359 China Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 360 China Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 361 Japan Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 362 Japan Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 363 Japan Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 364 Japan Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 365 Japan Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 366 Japan Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 367 Japan Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 368 Japan Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 369 Japan Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 370 Japan Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 371 Japan Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 372 Japan Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 373 India Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 374 India Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 375 India Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 376 India Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 377 India Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 378 India Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 379 India Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 380 India Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 381 India Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 382 India Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 383 India Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 384 India Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 385 South Korea Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 386 South Korea Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 387 South Korea Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 388 South Korea Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 389 South Korea Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 390 South Korea Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 391 South Korea Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 392 South Korea Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 393 South Korea Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 394 South Korea Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 395 South Korea Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 396 South Korea Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 397 Singapore Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 398 Singapore Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 399 Singapore Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 400 Singapore Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 401 Singapore Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 402 Singapore Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 403 Singapore Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 404 Singapore Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 405 Singapore Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 406 Singapore Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 407 Singapore Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 408 Singapore Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 409 Malaysia Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 410 Malaysia Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 411 Malaysia Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 412 Malaysia Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 413 Malaysia Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 414 Malaysia Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 415 Malaysia Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 416 Malaysia Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 417 Malaysia Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 418 Malaysia Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 419 Malaysia Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 420 Malaysia Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 421 Rest of Asia Pacific Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 422 Rest of Asia Pacific Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 423 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 424 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 425 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 426 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 427 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 428 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 429 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 430 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 431 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 432 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 433 LAMEA Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 434 LAMEA Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 435 LAMEA Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 436 LAMEA Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 437 LAMEA Branded Market by Country, 2018 - 2021, USD Million
TABLE 438 LAMEA Branded Market by Country, 2022 - 2028, USD Million
TABLE 439 LAMEA Generics Market by Country, 2018 - 2021, USD Million
TABLE 440 LAMEA Generics Market by Country, 2022 - 2028, USD Million
TABLE 441 LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 442 LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 443 LAMEA Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 444 LAMEA Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 445 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 446 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 447 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 448 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 449 LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 450 LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 451 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
TABLE 452 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
TABLE 453 LAMEA Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 454 LAMEA Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 455 LAMEA Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 456 LAMEA Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 457 LAMEA Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 458 LAMEA Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 459 LAMEA Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 460 LAMEA Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 461 LAMEA GERD Market by Country, 2018 - 2021, USD Million
TABLE 462 LAMEA GERD Market by Country, 2022 - 2028, USD Million
TABLE 463 LAMEA IBS Market by Country, 2018 - 2021, USD Million
TABLE 464 LAMEA IBS Market by Country, 2022 - 2028, USD Million
TABLE 465 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 466 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 467 LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 468 LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 469 LAMEA Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 470 LAMEA Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 471 LAMEA Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 472 LAMEA Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 473 LAMEA Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 474 LAMEA Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 475 LAMEA Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 476 LAMEA Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 477 LAMEA Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 478 LAMEA Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 479 LAMEA Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 480 LAMEA Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 481 LAMEA Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 482 LAMEA Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 483 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 484 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 485 LAMEA Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 486 LAMEA Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 487 Brazil Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 488 Brazil Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 489 Brazil Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 490 Brazil Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 491 Brazil Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 492 Brazil Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 493 Brazil Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 494 Brazil Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 495 Brazil Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 496 Brazil Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 497 Brazil Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 498 Brazil Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 499 Argentina Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 500 Argentina Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 501 Argentina Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 502 Argentina Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 503 Argentina Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 504 Argentina Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 505 Argentina Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 506 Argentina Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 507 Argentina Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 508 Argentina Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 509 Argentina Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 510 Argentina Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 511 UAE Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 512 UAE Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 513 UAE Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 514 UAE Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 515 UAE Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 516 UAE Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 517 UAE Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 518 UAE Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 519 UAE Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 520 UAE Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 521 UAE Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 522 UAE Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 523 Saudi Arabia Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 524 Saudi Arabia Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 525 Saudi Arabia Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 526 Saudi Arabia Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 527 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 528 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 529 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 530 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 531 Saudi Arabia Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 532 Saudi Arabia Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 533 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 534 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 535 South Africa Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 536 South Africa Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 537 South Africa Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 538 South Africa Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 539 South Africa Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 540 South Africa Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 541 South Africa Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 542 South Africa Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 543 South Africa Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 544 South Africa Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 545 South Africa Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 546 South Africa Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 547 Nigeria Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 548 Nigeria Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 549 Nigeria Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 550 Nigeria Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 551 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 552 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 553 Nigeria Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 554 Nigeria Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 555 Nigeria Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 556 Nigeria Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 557 Nigeria Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 558 Nigeria Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 559 Rest of LAMEA Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 560 Rest of LAMEA Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 561 Rest of LAMEA Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 562 Rest of LAMEA Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 563 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 564 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 565 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 566 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 567 Rest of LAMEA Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 568 Rest of LAMEA Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 569 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 570 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 571 Key Information – Abbott Laboratories
TABLE 572 Key information – AbbVie, Inc.
TABLE 573 Key Information – Takeda Pharmaceutical Company Limited
TABLE 574 Key Information – Pfizer, Inc.
TABLE 575 key information – Salix Pharmaceuticals, Inc.
TABLE 576 Key information –Johnson & Johnson
TABLE 577 KEY INFORMATION – AstraZeneca PLC
TABLE 578 Key Information – Bayer AG
TABLE 579 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 580 Key Information – Cipla Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Gastrointestinal Therapeutics Market Share by Type, 2021
FIG 3 Global Gastrointestinal Therapeutics Market Share by Type, 2028
FIG 4 Global Gastrointestinal Therapeutics Market by Type, 2018 - 2028, USD Million
FIG 5 Global Gastrointestinal Therapeutics Market Share by Distribution Channel, 2021
FIG 6 Global Gastrointestinal Therapeutics Market Share by Distribution Channel, 2028
FIG 7 Global Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2028, USD Million
FIG 8 Global Gastrointestinal Therapeutics Market Share by Route of Administration, 2021
FIG 9 Global Gastrointestinal Therapeutics Market Share by Route of Administration, 2028
FIG 10 Global Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2028, USD Million
FIG 11 Global Gastrointestinal Therapeutics Market Share by Application, 2021
FIG 12 Global Gastrointestinal Therapeutics Market Share by Application, 2028
FIG 13 Global Gastrointestinal Therapeutics Market by Application, 2018 - 2028, USD Million
FIG 14 Global Gastrointestinal Therapeutics Market Share by Drug Class, 2021
FIG 15 Global Gastrointestinal Therapeutics Market Share by Drug Class, 2028
FIG 16 Global Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2028, USD Million
FIG 17 Global Gastrointestinal Therapeutics Market Share by Region, 2021
FIG 18 Global Gastrointestinal Therapeutics Market Share by Region, 2028
FIG 19 Global Gastrointestinal Therapeutics Market by Region, 2018 - 2028, USD Million
FIG 20 Swot analysis: Abbott laboratories
FIG 21 Recent strategies and developments: Takeda Pharmaceutical Company Limited